Literature DB >> 16185924

Accumulation of risk markers predicts the incidence of sudden death in patients with chronic heart failure.

Jun Watanabe1, Tsuyoshi Shinozaki, Nobuyuki Shiba, Kohei Fukahori, Yoshito Koseki, Akihiko Karibe, Masahito Sakuma, Masahito Miura, Yutaka Kagaya, Kunio Shirato.   

Abstract

BACKGROUND: Sudden death is common in chronic heart failure (CHF). Risk stratification is the first step for primary prevention. AIM: To evaluate the use of risk markers for estimating sudden death risk. METHODS AND
RESULTS: We prospectively examined 680 stable patients with CHF. Risk markers were evaluated using the Cox's proportional hazard model in a stepwise manner. Ejection fraction <30%, left ventricular end-diastolic diameter >60 mm, brain natriuretic peptide >200 pg/ml, non-sustained ventricular tachycardia, and diabetes were significantly associated with increased risk of sudden death. When the number of risk markers were included as co-variables, only "number of risk markers >or=3'' entered the model (hazard ratio 8.95, 95% confidence interval 4.57-17.52), while the effects of individual markers did not enter the model. The annual mortality from sudden death was 11% in patients with 3 or more risk markers and 1.4% in patients with 2 or less.
CONCLUSIONS: Rather than particular risk markers, the number of accumulated risk markers was a more powerful predictor for sudden death in patients with CHF. The number of risk markers could be useful for risk stratification of sudden death.

Entities:  

Mesh:

Year:  2005        PMID: 16185924     DOI: 10.1016/j.ejheart.2005.08.003

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  12 in total

Review 1.  Arrhythmic risk stratification in heart failure: Time for the next step?

Authors:  Konstantinos A Gatzoulis; Antonios Sideris; Emmanuel Kanoupakis; Skevos Sideris; Nikolaos Nikolaou; Christos-Konstantinos Antoniou; Theofilos M Kolettis
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-02-03       Impact factor: 1.468

2.  Association of CASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease.

Authors:  Marwan M Refaat; Bradley E Aouizerat; Clive R Pullinger; Mary Malloy; John Kane; Zian H Tseng
Journal:  Heart Rhythm       Date:  2014-01-17       Impact factor: 6.343

3.  Ranolazine Therapy Reduces Non-ST-Segment-Elevation Myocardial Infarction and Unstable Angina in Coronary Disease Patients with Angina.

Authors:  Gary L Murray; Joseph Colombo
Journal:  Int J Angiol       Date:  2016-04-28

4.  Predictors of serious arrhythmic events in patients with nonischemic heart failure.

Authors:  Mauricio Pimentel; André Zimerman; Diego Chemello; Vanessa Giaretta; Michael Andrades; Daiane Silvello; Leandro Zimerman; Luis E Rohde
Journal:  J Interv Card Electrophysiol       Date:  2016-12-10       Impact factor: 1.900

5.  High incidence of ventricular arrhythmias in patients with left ventricular enlargement and moderate left ventricular dysfunction.

Authors:  Shuang Zhao; Keping Chen; Yangang Su; Wei Hua; Jiefu Yang; Silin Chen; Zhaoguang Liang; Wei Xu; Shu Zhang
Journal:  Clin Cardiol       Date:  2016-09-09       Impact factor: 2.882

6.  Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias.

Authors:  Anita Spezzacatene; Gianfranco Sinagra; Marco Merlo; Giulia Barbati; Sharon L Graw; Francesca Brun; Dobromir Slavov; Andrea Di Lenarda; Ernesto E Salcedo; Jeffrey A Towbin; Jeffrey E Saffitz; Frank I Marcus; Wojciech Zareba; Matthew R G Taylor; Luisa Mestroni
Journal:  J Am Heart Assoc       Date:  2015-10-16       Impact factor: 5.501

Review 7.  Chronic heart failure in Japan: implications of the CHART studies.

Authors:  Nobuyuki Shiba; Hiroaki Shimokawa
Journal:  Vasc Health Risk Manag       Date:  2008

Review 8.  Carvedilol in the treatment of elderly patients with chronic heart failure.

Authors:  Klaus K A Witte; Andrew L Clark
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

9.  Ranolazine preserves and improves left ventricular ejection fraction and autonomic measures when added to guideline-driven therapy in chronic heart failure.

Authors:  Gary L Murray; Joseph Colombo
Journal:  Heart Int       Date:  2014-12-22

10.  Ranolazine improves autonomic balance in heart failure when added to guideline-driven therapy.

Authors:  Gary L Murray; Joseph Colombo
Journal:  Heart Int       Date:  2014-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.